The Department of Health is to offer all children aged between six months and up to four years of age added protection against Hib disease by introducing a booster dose of Hib vaccine. This follows advice from the Joint Committee on Vaccination and Immunisation (JCVI) who recently made recommendations to the Department after considering the recent but small increase in cases of Haemophilus influenzae type b (Hib) disease, which can cause a number of serious illnesses in children including meningitis. Since 1992, all children have been routinely immunised at two, three and four months against the disease. This campaign has been a huge success with cases of Hib falling dramatically, almost disappearing in young children. However, there has been a very small but gradual increase in the number of cases of Hib disease reported since 1998. Although this number is small (122 cases in 2002) and much lower than the levels seen before the introduction of Hib vaccine (around 800 every year) it is still significant. The Chief Medical Officer, Sir Liam Donaldson, has written to GPs and other health professionals today informing them of the planned campaign which it is anticipated will start in Spring of this year. Sir Liam said: "I have written to health professionals in England to give them advance notice of our plans to introduce a Hib immunisation catch-up campaign. "Vaccinating children against Hib disease has proved very successful in cutting rates of this disease. Over the last ten years this vaccination has prevented about 7,300 cases of Hib disease and approximately 270 deaths in children aged under four. However our advanced disease surveillance programme has identified a small but significant increase in cases of Hib recently. In order to halt and reverse this increase, a Hib vaccination catch-up campaign is being planned. "We recognise the vital role that all health professions play in implementing our immunisation programme, and we recognise their need to be informed of our plans. We will be working closely with health professionals to finalise plans for the programme and parents will be invited to bring their children for immunisation in the same way as other childhood vaccines." The new 'catch-up' campaign to reverse the reported increase will be a booster dose of Hib vaccine offered to all children over the age of six months and less than four years on April 1 2003. It is anticipated the campaign will last four months. Notes for editors Hib is the term commonly used to describe a disease caused by the bacteria Haemophilus influenzae type b. Hib disease can cause a number of serious illnesses in children including meningitis, infection in joints, pneumonia and epiglottitis (causing swelling of part of the windpipe causing noisy, painful breathing and even blockage of the airway). The disease is most common in children under four years of age (with the exception of children aged under 3 months where it is rare). The infection is uncommon in children of 4 years of age or over. The Hib vaccination programme has been highly successful. Hib disease fell dramatically with the almost complete disappearance in young children by 1996. Cases of Hib disease also declined in children and adults who had not been immunised because less disease was circulating in the population. We estimate that over the last ten years, Hib vaccination has prevented about 7300 cases of Hib disease and approximately 270 deaths in children aged under four in England and Wales. It has also prevented an estimated further 400 cases and 11 deaths in all people aged over four years. Laboratory reports of Hib disease in England and Wales (1990-2002). *provisional data Source PHLS, HRU/CDSC Because of the very advanced systems in the UK for monitoring the rates of diseases, and monitoring the impact of immunisation, a small but gradual increase in the number of cases of Hib disease has been identified. The number of cases (122 cases in 2002) in children aged under 4 is much lower than the levels seen before the introduction of Hib vaccine (around 800 every year). The start date of the programme will be announced, together with further details, as soon as possible. For media enquiries only, please contact David Daley in the Department of Health Media Centre on 020 7210 4860. [ENDS]